© 2021 MJH Life Sciences™ and HCPLive - Clinical news for connected physicians. All rights reserved.
Latest Conference Articles
The HCPLive conference coverage page features articles, videos, and expert-led live coverage from major medical meetings throughout the year.
José-Alain Sahel, MD: Safety, Efficacy of Optogenetic Treatment for Retinitis Pigmentosa
November 19th 2021, 7:00pm
American Academy of Ophthalmology
At AAO 2021, Dr. Sahel discussed the findings of the PIONEER trial on the combination of an optogenetics device and gene therapy in treatment of RP.
Robert L. Avery, MD Highlights Results on RGX-314 For the Treatment Of Wet AMD
November 17th 2021, 8:00pm
American Academy of Ophthalmology
Dr. Avery discusses the positive results of RGX-314 gene therapy, noting dramatic reduction in need for therapy, with stable vision and good thickness results
Dilsher S. Dhoot, MD: Efficacy of Brolucizumab in Treatment of Diabetic Macular Edema
November 16th 2021, 10:00pm
American Academy of Ophthalmology
Dr. Dhoot discusses data on visual acuity from the phase 3 KESTREL and KITE trials, comparing brolucizumab to aflibercept at 52 weeks.
Abrocitinib Dosing Effective in Atopic Dermatitis Management
November 16th 2021, 9:00pm
Investigators said that patient-reported outcomes from the 2 abrocitinib groups showed greater efficacy than the dupilumab and placebo groups.
Study Evaluates Sun Protection Awareness in Adolescents
November 16th 2021, 5:00pm
Respondents suggested that increasing product availability and demonstrating the consequences of sunburn could increase sun protection among young people.
Arshad Khanani, MD Discusses Adverse Ocular Events After Brolucizumab Treatment
November 16th 2021, 4:00pm
American Academy of Ophthalmology
Dr. Khanani highlights data from MERLIN showing noninferiority of brolucizumab to aflibercept in nAMD treatment, but a higher rate of intraocular inflammation.
Veeral Sheth, MD: Identifying Durability, Safety of GB-102 in Wet AMD Treatment
November 16th 2021, 1:00pm
American Academy of Ophthalmology
Dr. Sheth discusses the data from the late-breaking Phase 2B ALTISSIMO study.
Boni Elewski, MD: Biologics for Pediatric Psoriasis Patients
November 15th 2021, 10:00pm
Dr. Elewski hopes that in the future more clinicians will prescribe biologics such as secukinumab and etancercept for the treatment of psoriasis.
Lisa Swanson, MD: Detailing Infantile Hemangioma
November 15th 2021, 9:00pm
Though not all hemangioma last past 10 years old in pediatric patients, some untreated hemangioma are associated with high risk of ulceration.
Saakshi Khattri,MD: Evolving Therapies for Psoriatic Disease
November 15th 2021, 8:00pm
Though Dr. Khattri felt the diagnosis of psoriatic arthritis had been “stagnant”, the inclusion of biologic therapies and more has been a welcomed change.